Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification and Comprehensive Analysis of FREM2 Mutation as a Potential Prognostic Biomarker in Colorectal Cancer

18 Feb 2022

Abstract excerpt

Gene mutations play an important role in tumor progression. This study aimed to identify genes that were mutated in colorectal cancer (CRC) and to explore their biological effects and prognostic value in CRC patients. We performed somatic mutation analysis using data sets from The Cancer Genome Atlas and International Cancer Genome Consortium, and identified that FREM2 had the highest mutation frequency in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Congenital gastrointestinal and neural anomalies
Share to Inflammatory Bowel Disease
Share to Protein Tyrosine Phosphatases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35252356
DOI: 10.3389/fmolb.2022.839617

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification and Comprehensive Analysis of FREM2 Mutation as a Potential Prognostic Biomarker in Colorectal CancerPMID 35252356Read ↗

Prognosis model of colorectal cancer patients based on NOTCH3, KMT2C, and CREBBP mutationsSemantic proximity Read ↗

Construction and validation of a colon cancer prognostic model based on tumor mutation burden-related genes.Semantic proximity Read ↗

Systematic Expression Analysis of the Diagnostic and Prognostic Value of HEPACAM Family Member 2 in Colon AdenocarcinomaSemantic proximity Read ↗

USH2A Mutation is Associated With Tumor Mutation Burden and Antitumor Immunity in Patients With Colon AdenocarcinomaSemantic proximity Read ↗

Correlation of KMT2 family mutations with molecular characteristics and prognosis in colorectal cancer.Semantic proximity Read ↗

KMT2C mutation as a predictor of immunotherapeutic efficacy in colorectal cancer.Semantic proximity Read ↗

Multi gene mutation signatures in colorectal cancer patients: predict for the diagnosis, pathological classification, staging and prognosis.Semantic proximity Read ↗

Identification and Validation of HEPACAM family member 2 is Correlated with Immune Infiltration as a Prognostic Biomarker in colon adenocarcinomaSemantic proximity Read ↗

Mutation patterns in colorectal cancer and their relationship with prognosisSemantic proximity Read ↗

Characterization of Genomic Alterations in Colorectal Liver Metastasis and Their Prognostic ValueSemantic proximity Read ↗

Comprehensive Analysis and Experimental Validation of HEPACAM2 as a Potential Prognosis Biomarker and Immunotherapy Target in Colorectal CancerSemantic proximity Read ↗

Single‐Cell RNA‐Seq Recognized Key Genes for Metastasis and Macrophage Infiltration in Colorectal CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.